Drugs - HealthQuill

Merck & Co.’s two oral cholesterol pill trials — one mid-stage and the other end-stage — showed “positive top-line results” on the efficacy and safety of the treatment in adults, according to the company.

Merck’s oral pill for bad cholesterol shows ‘positive’ data during trials

HQ Team June 10, 2025: Merck & Co.’s two oral cholesterol pill trials — one mid-stage and the other end-stage — showed “positive.

by HealthQuill
June 10, 2025
0 Comments

Underreporting of brain tumour cases and non-availability of neuroimaging facilities in India may be the cause of the low prevalence of the disease in the South Asian nation, experts say.

Drugs Health Pharma

India’s few neuroimaging units hinder tracking brain tumours

HQ Team June 10, 2025:Underreporting of brain tumour cases and non-availability of neuroimaging facilities in India may be the cause of the low.

by HealthQuill
June 10, 2025
0 Comments

The Food and Drug Administration has approved Merck & Co. Inc.’s jab for preventing respiratory syncytial virus (RSV) in infants up to one year of age for the first RSV season.

Drugs Health Pharma

Merck & Co.’s RSV injection for infants gets nod from US drug regulator

HQ Team June 10, 2025: The Food and Drug Administration has approved Merck & Co. Inc.’s jab for preventing respiratory syncytial virus (RSV).

by HealthQuill
June 10, 2025
0 Comments

Drugs Health Research

Mental disorders in ASEAN rise 70% in three decades: IHME, NUS study

HQ Team June 5, 2025: Mental disorders have risen 70% across three decades, starting in 1990, in the Association of Southeast Asian Nations.

by HealthQuill
June 5, 2025
0 Comments

Pfizer Inc. will pay Basilea Pharmaceutica Ltd. $ 2.5 million as the Swiss biopharmaceutical company exceeded the sales threshold of its antifungal therapy in the Asia Pacific region, triggering a milestone payment.

Drugs Health Pharma

Sales surge triggers Pfizer’s $2.5 million milestone payment to Basilea

HQ Team June 5, 2025: Pfizer Inc. will pay Basilea Pharmaceutica Ltd. $ 2.5 million as the Swiss biopharmaceutical company exceeded the sales.

by HealthQuill
June 5, 2025
0 Comments

Paradromics Inc., a US-based neurotechnology company, has completed its first-in-human surgical placement of its brain-computer interface.

Drugs Health Medical

Paradromics places brain-computer device in human, rivals Neuralink

HQ Team June 5, 2025: Paradromics Inc., a US-based neurotechnology company, has completed its first-in-human surgical placement of its brain-computer interface. The safe.

by HealthQuill
June 5, 2025
0 Comments

Eli Lilly and Company and Sweden’s Camurus AB have signed a $870 million pact to develop incretin products for diabetes and other chronic diseases.

Drugs Health Pharma

Lilly, Sweden’s Camurus sign $870 million pact for incretin products

HQ Team June 4, 2025: Eli Lilly and Company and Sweden’s Camurus AB have signed a $870 million pact to develop incretin products.

by HealthQuill
June 4, 2025
0 Comments

British-Swedish AstraZeneca Plc.’s investigational pill to treat an advanced breast cancer has reduced the chance of worsening the disease or the patient dying by 56% compared to the usual treatment.

Drugs Health Pharma

AstraZeneca’s pill to treat breast cancer cuts disease worsening by 56%

HQ Team June 4, 2025: British-Swedish AstraZeneca Plc.’s investigational pill to treat an advanced breast cancer has reduced the chance of worsening the.